FDA: Common Diabetes Drug Januvia May Contain Traces of Carcinogen

FRIDAY, Aug. 12, 2022 -- The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administration announced...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news